Cytori Therapeutics Inc., of San Diego, said an investigator-sponsored trial has been cleared to start in France to study the company's cell therapy as a potential treatment for limited and diffuse cutaneous systemic sclerosis.
Suite: 1100 | Atlanta, Georgia 30346, USA
Outside of the US
In the U.S. and Canada: +1-877-857-2477
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
Sign up for Highlights FREE e-mail newsletter